Pardon M C, Joubert C, Perez-Diaz F, Christen Y, Launay J M, Cohen-Salmon C
UMR 7593 CNRS, Hôpital de la Salpêtrière, Paris, France.
Mech Ageing Dev. 2000 Feb 15;113(3):157-68. doi: 10.1016/s0047-6374(99)00107-4.
It is well recognized that Ginkgo biloba extract (EGb 761) exert beneficial effects against various age-related changes and is able to reduce the negative influence of stress. In view of the age-dependent increase in the activity of the B form of monoamine oxidase (MAO-B) and in view of the anti-stress action of EGb 761 hypothetically attributed to an inhibition of monoamine oxidase by this substance, we investigated the effects of long-term treatment with EGb 761 upon in vivo cerebral MAO-A and -B activities of stressed and unstressed 17- and 18-month-old mice. The stress was a 'chronic mild stress' regimen whose behavioral impact is known to be reduced by EGb 761. The results showed that: (1) EGb761 induced reductions in MAO activity in 18-month-old, but not in 17-month-old mice; the older animals having higher basal MAO activity; (2) in unstressed mice, EGb 761 appeared to reduce the age-induced increase in cerebral MAO activity; (3) MAO-A and -B activities of stressed and treated 18-month-old mice did not differ significantly from the levels observed in unstressed and untreated 17-month-old mice. These results may shed light on the anti-stress effects of Ginkgo biloba extract.
人们普遍认识到,银杏叶提取物(EGb 761)对各种与年龄相关的变化具有有益作用,并且能够减轻压力的负面影响。鉴于单胺氧化酶B型(MAO-B)的活性随年龄增长而增加,且鉴于EGb 761的抗应激作用据推测归因于该物质对单胺氧化酶的抑制作用,我们研究了长期用EGb 761治疗对17和18月龄应激和未应激小鼠体内脑MAO-A和-B活性的影响。应激采用“慢性轻度应激”方案,已知EGb 761可减轻其行为影响。结果表明:(1)EGb761可使18月龄小鼠的MAO活性降低,但对17月龄小鼠无此作用;年龄较大的动物基础MAO活性较高;(2)在未应激小鼠中,EGb 761似乎可降低年龄引起的脑MAO活性增加;(3)应激并接受治疗的18月龄小鼠的MAO-A和-B活性与未应激且未治疗的17月龄小鼠所观察到的水平无显著差异。这些结果可能有助于阐明银杏叶提取物的抗应激作用。